DavidLichterMD

PubMed

• Proposal to Add FDG-PET as an Outcome Measure for Clinical Trials in Patients With Prodromal Lewy Body Dementia.
  David G Lichter, Linda A Hershey
  Neurology. 2023-10-10
• 16 citations
  Freezing of Gait in Parkinson's Disease: Risk Factors, Their Interactions, and Associated Nonmotor Symptoms.
  David Lichter, Ralph Holmes Boring Benedict, Linda A. Hershey
  Parkinson's Disease. 2021-01-12
• 14 citations
  Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's dis...
  Dejan Jakimovski, Niels Bergsland, Michael G. Dwyer, Jesper Hagemeier, Deepa P. Ramasamy
  Neurobiology of Aging. 2020-02-08

Journal Articles

• Substance use disorder in adult Tourette syndrome: frequency, profile and co-morbidities. Mind and Brain  
  Lichter, DG, The Journal of Psychiatry, 7/1/2011
• Before chorea: Pre-Huntington mild cognitive impairment.  
  Lichter DG, Hershey LA, Neurology, 1/1/2010
• Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open label study.  
  Edwards K, Royall D, Hershey L, Lichter D, Hake A, Farlow M, Pasquier F, Johnson S, Dement Geriatr Cogn Disord, 1/1/2007
• Cognitive and behavioral changes in progressive supranuclear palsy.  
  Hershey LA, Lichter DG, MedLink Neurology, 1/1/2006
• Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 12-week interim analysis.  
  Edwards KR, Hershey L, Wray L, Bednarczyk EM, Lichter D, Farlow M, Johnson S, Dement Geriatr Cogn Disord, 1/1/2004
• A pilot study of the effect of emotional stimuli on tic severity in children with Tourette Syndrome.  
  Wood BL, Klebba K, Gbadebo O, Lichter D, Kurlan R, and Miller B, Movement Disorders, 1/1/2003
• To test or not to test? That is the question (with a twist).  
  Lichter DG, Lang AE, Neurology, 1/1/2000
• Carotid Endarterectomy (ACE) Trial collaborators: Low-dose high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomized controlled trial.  
  Taylor DW, Barnett HJM, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE, Simard D, Silver FL, Hachinski V, Clagett GP, Barnes R, Spence JD, Lancet, 1/1/1999
• Influence of family history on clinical expression of Tourette Syndrome.  
  Lichter DG, Dmochowski J, Jackson LA, Trinidad KS, Neurology, 1/1/1999
• Slowed reaction time during a continuous performance test in children with Tourette's syndrome.  
  Shucard DW, Benedict RHB, Tekok-Kilic A, Lichter D, Neuropsychology, 1/1/1997
• Predictors of Clonidine Response in Tourette Syndrome: Implications and Inferences.  
  Lichter DG, Jackson LA, J. Child Neurol, 1/1/1996
• Parkinsonism associated with fluoxetine and cimetidine: a case report.  
  Leo RJ, Lichter DG, Hershey LA, J. Geriatr Psychiatry Neurol, 1/1/1995
• Clinical evidence of genomic imprinting in Tourette's syndrome.  
  Lichter DG, Jackson LA. Schacter M, Neurology, 1/1/1995
• Micrographia with cognitive dysfunction: "Minimal" sequelae of a putaminal infarct.  
  Pullicino P, Lichter D, Benedict R, Movement Disorders, 1/1/1994
• Levodopa drug holiday versus drug dosage reduction in Parkinson's disease?  
  Kurlan R, Tanner CM, Goetz C, Sutton J, Lichter D, et al, Clinical Neuropharmacology, 1/1/1994
• Tremor at onset: Predictor of cognitive and motor outcome in Parkinson's disease?  
  Hershey LA, Feldman BJ, Kim KY, Lein C, Lichter DG, Arch Neurol, 1/1/1991
• Carbamazepine-induced Tics.  
  Kurlan R, Kersun J, Behr J, Leibovici A, Tariot P, Lichter D, Shoulson I, Clinical Neuropharmacology, 1/1/1989
• Sensory Tics in Tourette's Syndrome  
  Kurlan R, Lichter D, Hewitt D, Neurology, 1/1/1989
• Erratic Gastric Emptying of Levodopa May Cause "Random" Oscillations of Parkinsonian Mobility  
  Kurlan R, Rothfield K, Woodward W, Nutt J, Miller C, Lichter D, Shoulson I, Neurology, 1/1/1988
• Opiate Withdrawal Unmasks Tourette's Syndrome.  
  Lichter DG, Majumdar L, Kurlan R, Clinical Neuropharmacology, 1/1/1988
• Cognitive and Motor Dysfunction in Parkinson's disease: Clinical, Performance and CT correlations.  
  Lichter DG, Corbett AJ, Fitzgibbon GN et al, Arch Neurol, 1/1/1988
• Duodenal and Gastric Delivery of Levodopa in Parkinsonism  
  Kurlan R, Nutt JG, Woodward WR, Rothfield K, Lichter D, Miller C, Carter JH, Shoulson I, Ann. Neurol., 1/1/1988
• Join now to see all

Books/Book Chapters

• Behavioral Neurology and Neuropsychiatry 
  Chapter: Frontal-Subcortical Circuits 
  Page 59 - 87Lichter, DGEditors: Arciniegas DB, Anderson CA, Filley CM.Cambridge University Press, Cambridge, UK2013
• "MedLink Neurology+C233" 
  Chapter: Cognitive and behavioral changes in progressive supranuclear palsy. 
  Page 1 - 18Hershey LA, Bharucha KJ, Lichter DGEditors: S. Gilman.Medlink Corporation, San Diego, CA2011
• "MedLink Neurology" 
  Chapter: Cognitive and behavioral changes in progressive supranuclear palsy. 
  Page 1 - 13Hershey LA, Lichter DEditors: S. Gilman.Medlink Corporation, San Diego, CA2007
• "Frontal-Subcortical Circuits in Psychiatric and Neurological Disorders" 
  Editors: Lichter DG, Cummings JL.Guilford Press, New York, NY2001
• Frontal-Subcortical Circuits in Psychiatric and Neurological Disorders 
  Chapter: Introduction and Overview 
  Page 1 - 43Lichter DG, Cummings JL, Mega MEditors: Lichter DG and Cummings JL.Guilford Press, New York, NY2001
• Frontal-Subcortical Circuits in Psychiatric and Neurological disorders. 
  Chapter: Movement Disorders 
  Page 260 - 313Lichter DG, Cummings JL, Mega MEditors: Lichter DG and Cummings JL.Guilford Press, New York, NY2001
• Frontal-Subcortical Circuits in Psychiatric and Neurological disorders. 
  Chapter: Addictions and Frontal-Subcortical Circuits 
  Page 231 - 259Lichter DG, Cummings JL, Mega MEditors: Lichter DG and Cummings JL.Guilford Press, New York, NY2001
• Clinical Neurology 
  Chapter: Current Therapy 
  Page 1 - 35Kingston N, Goodman A, Moss A, Lichter DGEditors: AB Baker, RJ Joynt.Harper and Row, Philadelphia, PA1989
• Practice of Geriatrics 
  Chapter: Parkinson's Disease and Parkinsonian Syndromes 
  Page 336 - 349Lichter DGEditors: Duthie Jr EH and Katz R. Eds.R..W.B. Saunders Co., Orlando, FLEdition 3,1988
• Join now to see all

Abstracts/Posters

• Diagnostic and prognostic issues in adolescents with psychogenic tics.
  Lichter DG, Finnegan SG, Movement Disorders, 1/1/2012
• Paroxysmal non-kinesigenic dyskinesia, dystonia and gait disorder secondary to mild GLUT1 deficiency.
  Finnegan SG, Lichter DG, Movement Disorders, 1/1/2011
• Major determinants of psychosocial and occupational disability in adult Tourette syndrome.
  Lichter DG, Finnegan SG, Movement Disorders, 1/1/2010
• Substance use disorder in adult Tourette syndrome
  Lichter, DG, Movement Disorders, 1/1/2009
• Female gender is an independent predictor of tic severity in adult Tourette syndrome.
  Lichter, DG, Neurology, 1/1/2008
• Memantine may alleviate psychosis and cognitive dysfunction in dementia with Lewy bodies.
  Lichter DG, Wray L, Hershey LA, Movement Disorders, 1/1/2006
• Brain metabolic and clinical response to galantamine in dementia with Lewy bodies (DLB): A preliminary report.
  Lichter DG, Marton K, Bednarczyk EM, Wray L, Wack D, Hershey LA, Movement Disorders, 1/1/2004
• "Galantamine in the management of dementia with Lewy bodies".
  Lichter, DG with Dr. Edwards, American Psychiatric Association (APA) 156th Annual Meeting, San Francisco, CA, 5/17/2003
• "Depression and recovery after acute ischemic stroke: initial data on lacunar versus other stroke types".
  Lichter, DG with Drs. Baker, Hershey and Gresham, Rotman Institute Brain/Behavior Meeting, Toronto, CA, 3/1/2002
• Discrete influences on executive function in Tourette syndrome
  Lichter DG, Jackson LA, Bisker SM, Neurology, 1/1/2002
• Relative course of tics and behavioral symptoms in Tourette's syndrome.
  Lichter DG, Diegelman NM, Bisker SE, Jackson LA, Movement Disorders, 1/1/2001
• Risks of obsessive compulsive and self-injurious behaviors in Tourette syndrome.
  Lichter DG, Jackson LA, Trinidad KS, Neurology, 1/1/1998
• The relationship between Tourette's syndrome and "childhood schizophrenia."
  Lichter DG, Diegelman NM, Jackson LA., J. Neuropsychiatry Clin Neurosci, 1/1/1997
• Bilineal contributions to obsessive-compulsive behavior in Tourette's syndrome.
  Lichter DG, Diegelman NM, Jackson LA, Trinidad KS, J. Neuropsychiatry Clin Neurosci, 1/1/1997
• Genomic imprinting in Tourette's syndrome
  Lichter DG, Jackson LA, Schachter M, Neurology, 1/1/1997
• Influence of family history on clinical expression of Tourette syndrome.
  Lichter DG, Jackson LA, Trinidad KS, Neurology, 1/1/1997
• Allergies and Tourette's syndrome.
  Feigin A, Robertson M, Trinidad K, Lichter D, et al, Neurology, 1/1/1996
• Predictors of neuroleptic requirement following clonidine trial in Tourette syndrome.
  Lichter DG, Trinidad K, Jackson LA, Neurology, 1/1/1996
• "Usefulness of eight oculomotor signs in distinguishing early PSP from PD".
  Lichter, DG, with L.A. Hershey, 12th Annual Oculomotor Symposium, Washington, DC, 10/1/1995
• Executive dysfunction in Tourette syndrome: clinical correlates
  Lichter DG, Jackson LA, Schacter M, Neurology, 1/1/1995
• Longitudinal assessment of verbal and visual memory in Parkinson's disease patients.
  Donnelly KZ, Donnelly JP, Lichter DG, Hershey LA, Arch Clinical Neuropsychol, 1/1/1995
• "Usefulness of SPECT in distinguishing progressive supranuclear palsy from Parkinson's disease."
  Lichter, DG, with L.A. Hershey, 3rd International Congress of Movement Disorders, Orlando, FL, 11/1/1994
• Usefulness of SPECT in distinguishing progressive supranuclear palsy from Parkinson's disease.
  Hershey LA, Gona G, Husain S, Pares G, Spain J, Donnelly K, Olszewski W, Lichter D, Movement Disorders, 1/1/1994
• Childhood Tourette syndrome phenotype is influenced by gender of affected parent.
  Lichter DG, Stofko P, Jackson L, Schacter M, Neurology, 1/1/1993
• Blood pressure correlates and predictors of Clonidine response in Tourette Syndrome
  Lichter DG, Movement Disorders, 1/1/1992
• Join now to see all

Lectures

• "Female gender and adult Tourette Syndrome". 
  Movement disorder Society's 17th International Congress on Parkinson's Disease and Movement disorde - 6/16/2013
• "Diagnostic and prognostic issues in adolescents with psychogenic tics". 
  Movement Disorder Society's 16th International Congress of Parkinson's Disease and Movement Disorde - 6/17/2012
• "Parkinson's Disease: Clinical features, differential diagnosis and management". 
  CME lecture, WCA Hospital, Jamestown, NY - 10/5/2011
• "Paroxysmal non-kinesigenic dyskinesia, dystonia and gait disorder secondary to mild GLUT1 deficiency". 
  Movement Disorder Society's 15th International Congress of Parkinson's Disease and Movement Disorder - 6/5/2011
• "The Faces and Cases of Parkinson's Disease: Exploring the Challenges of Management of Early and Advanced Parkinson's Disease". 
  CME lecture (Center for Medical Knowledge), Rochester, NY - 9/1/2010
• "Major determinants of psychosocial and occupational disability in adult Tourette syndrome": 
  Movement Disorder Society's 14th International Congress of Parkinson's Disease and Movement Disorder - 6/13/2010
• "Low-dose naltrexone's tolerability and effects in fatigued patients with Parkinson's disease: an open-label study". 
  American Society for Experimental NeuroTherapeutics, Washington, DC - 3/1/2010
• "Shifting paradigms in the diagnosis and treatment of Parkinson's disease". 
  CME program, Bethlehem, PA - 11/4/2009
• "Substance use disorder in adult Tourette syndrome". 
  Movement Disorder Society's 13th International Congress of Parkinson's Disease and Movement Disorde - 6/7/2009
• "Restless legs syndrome: epidemiologic, genetic, pathophysiologic and clinical aspects" 
  Grand Rounds, Albany Medical Center, Albany, NY - 3/26/2009
• "Parkinson's Disease Advanced Therapeutic Strategies (PATHS)" 
  National CME program (NCME), Buffalo, NY - 5/13/2008
• "Female gender is an independent predictor of tic severity in adult Tourette syndrome". 
  60th Annual Meeting of the American Academy of Neurology, Chicago, NY - 4/12/2008
• "New options for the treatment of restless legs syndrome". 
  Visiting Speaker's Program, Boehringer-Ingelheim Pharmaceuticals, Bradford, PA - 9/18/2007
• "Current approaches in treating Parkinson's disease". 
  American Health Resources PharmEd CE Program, Buffalo, NY - 6/1/2007
• "Restless legs syndrome". 
  Neurology Grand Rounds, Buffalo, NY; Visiting Speaker's Program, Boehringer-Ingelheim Pharmaceutical - 4/1/2007
• "Memantine may alleviate psychosis and cognitive dysfunction in dementia with Lewy bodies". 
  World Parkinson Congress, Washington, D.C. - 2/22/2006
• "Tourette Syndrome: Current and Experimental Therapy". 
  9th International Congress of Parkinson's Disease and Movement Disorders, New Orleans, USA; Neurolo - 3/5/2005
• "Parkinson's disease: Where are we? Where are we headed?" 
  Visiting Speaker's Program, Boehringer-Ingelheim/Pfizer Pharmaceuticals, Buffalo, NY - 3/1/2005
• "Parkinson's disease: current approaches to management". 
  Visiting Speaker's Program, Boehringer-Ingelheim/Pfizer Pharmaceuticals, Rochester, NY - 10/1/2004
• "Brain metabolic and clinical response to galantamine in dementia with Lewy bodies (DLB): A preliminary report". 
  8th International Congress of Parkinson's Disease and Movement Disorders, Rome, Italy - 6/13/2004
• "Tourette Syndrome: Neurobiology and Management". 
  Neurology Grand Rounds, Buffalo, NY; 8th International Congress of Parkinson's Disease and Movement - 2/1/2004
• "Galantamine is safe and effective in patients with dementia with Lewy bodies (DLB)". 
  3rd International Workshop on dementia with Lewy Bodies and Parkinson's Disease with Dementia (DLB/P - 9/17/2003
• "Results of a 24-week, open-label, flexible-dose trial to assess the safety and efficacy of galantamine in patients with dementia with Lewy bodies: an Interim analysis". 
  6th International Conference on Alzheimer's and Parkinson's Disease (AD/PD), Seville, Spain - 5/8/2003
• "Dementia with Lewy bodies: Interim analysis from the galantamine trial". 
  Neurology Grand Rounds, Buffalo, NY - 1/1/2003
• "Discrete influences on executive function in Tourette syndrome". 
  54th Annual Meeting of the American Academy of Neurology, Denver, CO - 4/1/2002
• Join now to see all

Other

• In-service training videotape for educators of children with Tourette Syndrome 
  Lichter, DG, S. Conners and R. Fisher-Collins, TSA National Board, and D. Pandolfino, Videotapes
  Manhattan Transfer Video Production Studios, Manhattan, NY - 1/1/1995